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Abstract
Vector borne disease (VBD) emergence is a complex and dynamic process. Interactions between multiple
disciplines and responsible health and environmental authorities are often needed for an effective early warning,
surveillance and control of vectors and the diseases they transmit. To fully appreciate this complexity, integrated
knowledge about the human and the vector population is desirable. In the current paper, important parameters
and terms of both public health and medical entomology are defined in order to establish a common language
that facilitates collaboration between the two disciplines. Special focus is put on the different VBD contexts with
respect to the current presence or absence of the disease, the pathogen and the vector in a given location.
Depending on the context, whether a VBD is endemic or not, surveillance activities are required to assess disease
burden or threat, respectively. Following a decision for action, surveillance activities continue to assess trends.
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Background
T h eE u r o p e a nC e n t r ef o rD i s e a s eP r e v e n t i o na n dC o n -
trol (ECDC) has a responsibility to identify, assess and
communicate current and emerging dangers to human
health from infectious diseases. Vector-borne diseases
(VBDs) pose a special challenge to ECDC and national
public health authorities due to their complex nature.
Interactions between multiple disciplines and responsi-
ble health and environmental authorities are often
needed for an effective early warning, surveillance and
control of vectors and the diseases they transmit.
Because many aspects of their complicated transmission
cycle are under strong influence of environmental con-
ditions (including weather), adequate risk assessment,
early detection, prevention and control of endemic and
emerging VBDs may demand approaches other than or
in addition to those developed for non-VBDs. This was
also recognized by ECDC and is their rationale for fund-
ing a network of both medical entomologists and public
health experts, VBORNET. The network addresses the
prerequisites for vector surveillance activities of arthro-
pods of importance to priority diseases in the European
Union. This paper aspires to bridge the gap between
entomologists and public health professionals and to
facilitate the communication between them. This first
strategic paper of the VBORNET project aims to pin-
point the relevance of the different surveillance elements
for VBDs important for public health in Europe.
Because of the current focus of ECDC on tick-borne
diseases, emphasis is placed on VBDs transmitted by
ticks in Europe, in particular Lyme borreliosis.
Definitions and basic concepts
Public health, medical entomology and vector-borne
diseases
Conventionally, public health is defined as the branch of
medicine concerned with the prevention and control of
disease and disability in a population, and the promo-
tion of physical and mental health of the population on
the international, national, or intra-national administra-
tive level. Currently, within the ‘one health’ initiative,
however, medicine is considered more a branch of pub-
lic health, due to the multidisciplinary character of the
latter.
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insect and other arthropod biology to disease transmis-
sion or sanitary matters. In addition to academic institu-
tions, medical entomologists are commonly employed
by vector control agencies, but only seldom by public
and veterinary health institutes or governmental policy-
making bodies.
I ng e n e r a l ,av e c t o r - b o r n ed i s e a s ei so n eo fw h i c ht h e
causative agent is transmitted between vertebrate hosts
by another organism (vector). Here, we use the defini-
tion in which an arthropod is required for the transmis-
sion and propagation of the pathogen. This narrow
definition for vector-borne diseases is used because this
class requires a common strategy for monitoring, sur-
veillance and also control. In contrast, for pathogens
that are optionally transmitted by vectors such as Cox-
iella or Salmonella, the approach for surveillance
requires also other strategies related to other transmis-
sion routes.
From a public health point of view, five different types
of VBD situations (contexts) are identified according to
a simplified tabulation of the current presence or
absence of the disease, the pathogen and the vector in a
given location (Table 1). Here, a VBD is considered pre-
sent when endemic infections in humans occur. In epi-
demiology, an infection is said to be “endemic” in a
human population when that infection is maintained in
the population without the need for external inputs
(note that, in ecology, an organism being “endemic”
means exclusively native to a place or biota). Further-
more, we consider a pathogen to be present, when it is
circulating among indigenous vectors and non-human
hosts, but also when it is regularly introduced by vectors
or reservoirs, including humans. A vector is considered
present when an arthropod capable of transmitting a
certain VBD is indigenous. We elaborate on the differ-
ent types of VBD contexts using the Netherlands as an
example (Table 1).
In the first VBD context, endemic human cases arise
through the transmission of a pathogen to a susceptible
human host from a reservoir host by an indigenous vec-
tor species. In the second VBD context, both pathogen
and the vector are present but no human cases occur
due to biotic, climatic, environmental or societal rea-
sons. Such a situation can exist when a pathogen
responsible for a zoonotic disease circulates in the ani-
mal reservoir and/or vector populations but without
causing human disease burden, either because humans
are not infected or because human infections go unno-
ticed. Low level circulation of West Nile virus in mos-
quitoes and birds in non-epidemic years in Italy and
France are other examples [1,2]. In the third VBD con-
text, a competent vector is present but the pathogen has
never been introduced and therefore there are no locally
transmitted human cases. The reverse circumstance is
described in the fourth VBD context where a pathogen
is frequently imported into a location where no compe-
tent vector is present, which precludes pathogen trans-
mission and therefore autochthonous human cases. The
frequent importation of Leishmania-infected dogs from
the Mediterranean countries to the Netherlands is an
example of the latter. Locations where both the vector
and pathogen are absent fall into the fifth type of VBD
contexts. Despite incidental findings of a Hyalomma
tick, the vector of Crimean-Congo haemorrhagic fever
(CCHF) [3], the situation of the Netherlands with
respect to CCHF is of the latter type.
In short, all endemic VBDs fall under context 1 and
the various non-endemic VBDs fall under one of the
remaining four contexts (2-5). To identify, assess, com-
municate and ultimately control VBDs, monitoring and
surveillance tools, appropriate to the context, are
needed.
VBD surveillance feedback system
A c c o r d i n gt oE C D C ,“Surveillance of health and disease
includes ongoing data collection, analysis to convert this
data into statistics, interpretation of this analysis to pro-
duce information and dissemination of this information
to those who can take appropriate action. At ECDC, this
process is aimed at providing appropriate, quality and
timely information for key stakeholders in Member States
and European Commission. This permits them to take
action by planning and implementing more effective, evi-
dence-based public health policies and strategies relevant
Table 1 Different types of VBD context based on the current presence (√) or absence (-) of disease (endemic human
cases), pathogen or vector, exemplified for the Netherlands
Context Endemic
Disease*
Pathogen Vector Examples of diseases holding for the Netherlands
1 √√ √ Lyme borreliosis
2- √√ Dirofilariasis
3- - √ Tick-borne encephalitis
4- √ - Leishmaniasis
5 - - - Crimean-Congo haemorrhagic fever
* Endemic infections with human cases.
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crisis situations as well as in the long term” (ECDC,
2011).
Generally, estimations of the current impact of a
health problem are made through calculations of the
burden of disease and the assessments of the impact of
future outbreaks in an area through quantitative micro-
bial risk assessments. While applicable for endemic
VBDs (context 1, Table 1, Figure 1), such quantitative
assessments would not be sensible for the remaining
VBDs contexts with no actual disease burden or risk
(the latter defined as probability times impact). Never-
theless information on these so-called threats to human
health is desirable.
Essential for the assessments of both the burden and
the health threat is the identification of the appropriate
indicators defined as measurable factors that allow deci-
sion makers to estimate objectively the size of a health
problem (disease burden) or severity of a threat. These
indicators should be appropriate for monitoring the pro-
cesses or the effects of intervention aiming at decreasing
the disease burden (VBD context 1) or preventing the
introduction of disease burden (VBD contexts 2-5). For
VBDs, indicators not only relate to occurrence of
human disease, but also on the abundance of pathogen
and/or vector (see Table 1, Figure 1). In addition to
identification of the adequate indicators, harmonization
(and communication) of these indicators across diseases
and countries would also be very advantageous.
Priority setting of communicable diseases has been
attempted in several countries. Disability-adjusted life
years (DALY) [4] are often used for a standardized
quantification of the disease burden. The DALY
approach combines mortality, incidence (and/or preva-
lence) of infection and the sequelae associated with an
infection on the population level into a single measure
[5-7]. Policy-makers use this indicator for setting priori-
ties in their decision-making. In order to obtain DALY
estimates, monitoring of disease indicators is required in
each country and demands a lot of effort. Data sets are
(still) not comparable across EU-countries, but efforts
are ongoing to develop and estimate disease burdens of
communicable diseases in Europe [8]. For non-endemic
infectious diseases (VBD contexts 2-5), however, the
priority setting process is more complex as there are no
endemic cases. Often an emerging infection is only a
threat and data on essential criteria for priority setting
for national or even the European situation may not be
available as there is no endemic or epidemic disease
burden. To quantify the threat of an emerging infection,
DALY’s per expected incident case need to be estimated
to assess the possible impact of an outbreak. Recently,
approaches of priority setting of emerging infectious dis-
eases, including VBDs, were described based upon a set
of criteria and expert opinions, where possible including
data from the available literature (http://www.ezips.rivm.
nl; [9,10]). Other priority-setting criteria for assessing
the threat of emerging pathogens entail their potential
to spread among the general population, their associated
socio-economic burden, their preventability, their poten-
tial to drive public health policy, their perceived risk for
public health, their temporal changes in occurrence and
their perceived potential to cause an outbreak.
Decision making, whether to intervene or not, needs
to follow the priority setting process taking cost-benefit
ratio into account. Especially, in a time of grim govern-
mental budget cuts, focusing on interventions that
achieve the largest health gain per euro spent is sensible.
For some VBDs, taking action even when as yet there is
no disease, might be preferable.
Once a decision to intervene has been made to
decrease the disease burden (or group/category of dis-
eases) or to mitigate a threat, surveillance should be
implemented in order to measure the effectiveness of
the intervention.
Within the VBD surveillance feedback system three
main situations can be distinguished:
1. The collected information does not directly pro-
vide estimations of disease burden or threat. Conse-
quently, they do not trigger decisions whether to
take action or not, but are merely carried out to
investigate unknowns of a VBDs transmission,
Figure 1 Simplified scheme for VBD surveillance feedback
system. Vertical yellow cylinders represent the categorical
collections of data (monitoring). Horizontal arrows represent the use
of selective set of data from monitoring activities for surveillance
purposes for a specific VBD context or VBD. The diamonds points at
the responsible health agency/decision makers and the triangles
represent the input of research and developmental studies. The EU
could play a pro-active role in the activities indicated in purple.
Other signals indicate signals that are not included in disease
burden or threat assessments but that affect decision-making.
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proportion infected ticks.
2. The information enables the estimation of disease
burden or threat. However, based on the provided
data, the decision was made that intervention is not
opportune. Surveillance activities continue to follow
trends in the situation.
3. The provided information on disease burden or
threat leads to the decision to intervene. Control
actions are developed and implemented. Surveillance
activities continue in order to measure the effective-
ness of the intervention on reducing disease burden
or threat. To do so, surveillance activities also assess
change in the direct intervention parameters. For
example, in a situation where intervention is imple-
mented to lower the disease burden of Lyme borre-
liosis by controlling ticks, the change in tick
numbers is assessed, and not only the change in dis-
ease burden.
Obviously, decision making is a crucial step in VBD
surveillance feedback system.
Data collection
Data collection is either passive or active. In veterinary
and public health systems, passive activities involve
voluntary or mandatory reporting of cases, either animal
or humans, that are ill enough to have consulted a prac-
titioner. Active systems involve ‘searching’ for evidence
of disease through routine, periodic or continuous data
collection [11]. Active surveillance provides the most
accurate and timely information but is also expensive
[12]. Passive activities are less expensive, but because
only infected subjects with clinical signs are included,
they do not provide complete information about the cir-
culation of a pathogen in the population (true
prevalence).
The following five types of data collection can be dis-
tinguished with respect to the parameter that is consid-
ered, exemplified by issues concerning VBDs:
1. Pathogen data collection that focuses on pathogen
detection and identification of all levels, including
human case, reservoir host, and intermediate host, but
also within the vector.
2. Serological data collection that aims at the detection
of exposure to a pathogen by monitoring immunological
responses in the blood of animals or humans.
3. Clinical data collection refers to the monitoring of a
clinical syndrome that has a significant impact on veter-
inary or public health, which is then used to drive deci-
sions about health policy and health education. In
human health this predominantly refers to passive sur-
veillance i.e. making use of data collected from patients
for other purposes than surveillance (e.g. declaration,
patient dossier or management). If additional data are
collected from the patient explicitly for public health
surveillance, it is called active or intensified surveillance.
Parallel collection of data from controls may be part of
the design in active surveillance allowing continuous
periodical case-control analysis. In that case the distinc-
tion with classical epidemiological case-control studies is
that data collection is not restricted to a predefined time
period.
4. Syndromic data collection refers to an active or pas-
sive system that uses case definitions that are based
entirely on clinical symptoms without any differential or
laboratory diagnosis.
5. Risk data collection that focuses not on prevalence
of pathogens or clinical features in animals or humans,
but on detecting risk factors for disease transmission.
The collection of data on the presence/absence and
abundance of vectors falls in this category. In addition,
it can also include behavioural risk factor surveillance
[12], which involves the active system of repeated sur-
veys that measure behaviours that are known to cause
infection (e.g. exposure to infected ticks). The presence
and activity of vectors are susceptible to weather (cli-
mate) and environmental conditions (flora, fauna, and
landscape design). These data also fall into this category.
Especially the presence of vectors can be obtained both
actively and passively (see section on parameter needs
for vector-borne disease monitoring in Europe).
The use of standards or the harmonization of data
collection, representation and reporting facilitates com-
parability of information over time, across different
approaches and across countries and regions, and allows
integration of collected data sets for more powerful ana-
lyses. To be credible, a standard should be developed
through open participatory process by an internationally
recognized accredited standards development organiza-
tion that is also capable of long-term maintenance and
evolution of standards [12].
Early warning and preparedness
Early warning is a system in which reception of certain
predefined signals will trigger interventions. For exam-
ple, upon the introduction of a certain exotic vector spe-
cies (a list of important invasive vector species should be
available), vector control measures will be taken. In
endemic situations an early warning is triggered when
the frequency of occurrence of a disease crosses a pre-
defined threshold [13].
Preparedness is a system in which scenarios are
described and public health authorities are prepared for
outbreaks of diseases prior to their arrival (see also Fig-
ure 1). In the case of an introduction of a certain patho-
gen, the authorities should have information available
on whether a vector is present or not. One of the conse-
quences of preparedness can be, for instance, that when
no competent vector is present (VBD context 4), no
Braks et al. Parasites & Vectors 2011, 4:192
http://www.parasitesandvectors.com/content/4/1/192
Page 4 of 11further actions will be taken to prevent the pathogen
from spreading in the country. However, the existing
knowledge must be carefully assessed before taking any
decision, especially considering the low level of under-
standing of the vectors’ transmission competence. A
more complicated situation can occur where action
might be needed, for instance when a sudden introduc-
tion of a new vector species occurs, as was the case
recently with the introduction of a mosquito species
imported with used tyres [14,15]. In this case immediate
action might be required, but at the same time, a con-
tingency plan, legal requirements and responsibilities
(for example on usage of pesticides) should already be
in place.
Parameter needs for vector-borne disease monitoring in
Europe
Disease burden
To decide which VBDs should preferably be controlled,
we need estimates of the actual disease burden for ende-
mic infections. To adequately monitor the disease bur-
den of VBDs related to their occurrence, information is
needed from different subgroups of the human popula-
tion, represented by a disease burden pyramid (see also
Figure 2). Patients, who are hospitalized or who died
form the top of this pyramid for which different moni-
toring systems are in place. The following layer contains
all laboratory confirmed cases, which are reported to the
surveillance system of a local or state health department.
Periodic epidemiological studies in the general popula-
tion are necessary to assess the total number of diseased
persons and the proportion that presents to the health
care system (layer 3 from the top of pyramid, Figure 2)
[16]. Ideally such a system for VBDs should involve
laboratory surveys, physician surveys, and population
surveys to collect information about each of these steps.
An additional layer in this pyramid about asymptomatic
and symptomatic cases estimated by serology [17] is
necessary for disease burden estimations.
Gathering data for the estimation of the disease bur-
den has been quite successful for several food-borne
infections [5]. However, hardly any data exist on the
basis of which the disease burden of VBDs can be esti-
mated. Alternatively, parameters that are indirect indi-
cators, so called proxies, of disease burden are used
and monitored. In quantitative microbiological risk
assessments, for example, data about those exposed
but not necessarily infected, is primarily needed. Infor-
mation about exposure to VBD agents depends on
contact patterns between humans and infected vectors.
These differ between mosquito-borne, tick-borne, and
sandfly-borne diseases, but also within these three
categories. Monitoring of contacts between humans
and vectors requires information about habitats of vec-
tors, behaviour and seasonality of vectors, and human
behaviour that enables the vector to bite or feed on
humans. Human behaviour can be monitored in popu-
lation surveys or by defined specific target groups with
possibly high risks of exposure (sentinel populations).
Possibly, web-based monitoring of human behaviour
offers an opportunity for monitoring trends in risk
behaviour. The usefulness of extending internet appli-
cations as for monitoring influenza (http://www.degro-
tegriepmeting.nl/) to VBDs should be investigated.
Serological surveys can give insight into changes in
exposure by estimating the number of seroconversions,
possibly both past and recent. Large population based
sero-surveys used for other purposes (e.g. effectiveness
of a national vaccination program [18]) could be
applied to test for antibodies against vector-borne
infections. Sero-surveys could be accompanied by
questionnaires concurrently asking for bites and
pathognomonic symptoms (e.g. erythema migrans
(EM) in case of Lyme borreliosis) in the past five
years. Trends in exposure similar to that of the results
of laboratory surveillance can be used to update earlier
disease burden estimates. The occurrence of (self-
reported) symptomatic infections (in case these are
pathognomonic for a certain disease), bites and care-
seeking, can be monitored prospectively via web-based
systems of questionnaires in large predefined cohorts
for a series of VBDs as done for other series of health
care questions (http://www.degrotegriepmeting.nl/).
Taken together such approaches may allow an estimate
of the number of symptomatic VBD infections [16] and
care seeking in the general population. A certain frac-
tion of symptomatic infections will be tested and diag-
nosed by a general practitioner (GP). For these
infections, a GP sentinel system can monitor trends in
testing and positivity. Comparing the testing rate with
the rate of self-reported symptomatic infections gives
an estimate of the fraction of infections that lead to a
GP visit and the fraction that remains untreated.
Figure 2 Intervention and surveillance pyramid for vector-
borne diseases.
Braks et al. Parasites & Vectors 2011, 4:192
http://www.parasitesandvectors.com/content/4/1/192
Page 5 of 11Hospital referral and sequelae to infections from VBDs
could be obtained from GP sentinel systems as well in
addition to data from hospital registration systems. Mor-
tality due to VBD, in principle, can be obtained from
mortality monitoring by cause of death.
Disease burden of Lyme borreliosis: An example
Although it is acknowledged that Lyme borreliosis is
increasing in many countries [19,20], the extent of the
problem is difficult to communicate to policy makers.
For Lyme borreliosis, attempts to estimate the disease
burden have been undertaken using an outcome tree
(Figure 3) and information about the incidence, cost of
illness and burden of each of the sequelae of the infec-
tion [21].
Due to the lack of the pathognomonic features of the
clinical symptoms with the exception of erythrema
migrans, and the very low sensitivity of serological tests,
incidence rates needed for estimating the disease burden
may be largely underestimated or uncertain. The lack of
evidence for Lyme borreliosis such as no tick noticed,
no erythrema migrans no positive serology will lead to
underdiagnosis and underreporting of the sequelae due
to the infection.
The number of tick bites relates to the entomological
risk index and depends on the tick population and con-
tact rate of humans and ticks (Figure 4). Exposure to
ticks in itself may lead to seeking medical care [22]. In
the Netherlands, monitoring GP consultations for tick
bites concurrently with answers from questionnaires in
the general population on tick bites [23] shows that one
out of fifteen tick bites leads to visiting a GP. Accurate
numbers of patients with consultations for EM exist as
well for the Netherlands [19,23]. Almost all of these
patients are expected to be treated according to national
medical guidelines. However, therapy failure in 10-20%
of cases is estimated in the literature [24,25]. Moreover,
at least an equal number of eythrema migrans patients
do not visit their GP and will only be treated after they
develop late-stage sequelae. Not all infections have an
early manifestation with an erythrema migrans, a range
from 75-90% with erythrema migrans is reported [26].
Anecdotal evidence suggests that depending on the Bor-
relia spp. this might even be as low as 50% or lower.
Clearly, getting the figures correct is a major challenge
warranting a concerted action on an international level.
In the Netherlands, methods measuring proxies of dis-
ease burden for Lyme disease are under development. In
2011, all physicians are approached to provide retro-
spective data and to forward extensive questionnaires to
their LB patients in the past 12 months. Patient ques-
tionnaires are used to reconstruct the evolution of their
disease, at what stage they started seeking medical care,
therapy failure, related costs and quality of life.
Parameter needs for vector and pathogen monitoring in
Europe
Threat
The data collection described above generally applies for
assessing disease burden of an endemic pathogen. How-
ever, the forecasting, early detection, prevention and
control of emerging VBDs assess threat (Table 1, con-
text 2-5) demand knowledge of other parameters.
Acquiring data on the density of (infected) vectors com-
plements to the disease burden pyramid for VBDs (Fig-
ure 2). In case of a zoonotic VBD, yet another level is
added, that of the number of (infected) reservoir hosts
(Figure 2). Infection rates of vectors are indicators of
risk of transmission. Sustained elevated infection rates
(assuming baseline data are available) are indicative for
an increased transmission risk. Combining the infection
rates with vector abundance (i.e. density/activity) will
result in a more accurate estimate of the risk of infec-
tion. An integrative approach combining the modelling
of the reproduction numbers of VBD and the construc-
tion of risk maps to predict the emergence of VBD was
described recently by Hartemink [27].
Vector sampling programs are essential to determine
presence/absence and abundance of vectors for risk sur-
veillance and preparedness, but also for pathogen sur-
veillance at the vector level. For the latter, it is
important to be able to distinguish between the different
Figure 3 Outcome tree for estimating disease burden of Lyme
borreliosis (LB). R: recovered. GP: general practitioner. An outcome
tree for estimating economic costs of LB is presented in [21].
Figure 4 Outcome tree of human exposure to ticks.
†total tick
bites is GP visits for tick bites times 15 (x) in the Netherlands [23].
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gens, or at least between non-pathogenic and pathogenic
species. Since VBDs, by definition, require vectors for
their transmission, the absence of vectors put the trans-
mission of VBDs to a halt. As a consequence, eradica-
tion or control of the vector population is an important
intervention tool for VBDs. To measure the effect of
vector control, indicators on the presence/absence and
abundance of the vector in a given location are essential.
In addition, the longevity of individual vectors is also an
important determinant, but difficult to monitor. The
control of the major host of the vector or the reservoir
host(s) of the pathogen may also be means to control
the disease.
Presence/absence and abundance data of vectors
While data on the size of the study population (and
consequently the sampling fraction) are readily available
for domestic animals and humans, basic information on
vector distribution and abundance does not exist for
most countries or locations. The most important epide-
miological parameters for vector monitoring are vector
diversity (presence/absence of species), spatial and tem-
poral variation in vector abundance and pathogen preva-
lence in the vector population. These parameters can
usually only be gathered through active vector surveil-
lances and pathogen prevalence assessment in the col-
lected vectors. In contrast to biases in passive
surveillance, sampling strategies in active surveillance
can be largely kept under control. Active surveillance,
however, is also more costly and labour intensive than
passive surveillance. In specific cases, involving mostly
ectoparasites such as ticks, passive surveillance alone
gives very useful information and is even preferred [28].
Sightings of species by the public or volunteers can aid
species diversity databases, but cannot be used for spa-
tio-temporal species mapping due to large biases. Since
arthropod species diagnostics is such a specialised area
of expertise, specimens that are collected by the public,
should not be included in such data-bases without veri-
fication by an expert. The down-side of passive surveil-
lance, generally, is that it comprises only presence data
of species (specimen) and not data showing the absence
of species. Absence data are just as important as pre-
sence data. But if no specimen of a species is collected
in an area, it does not prove that that species is absent
from that area; it might be rare, hiding, be in an inactive
state, be in a different type of habitat, or not be
responding to the trapping device used. In conclusion,
although absence data are generally more difficult, costly
and labour intensive to gather, they are indispensable for
surveillance of vector-borne diseases. Making presence/
absence maps of important vector species is essential for
determining to which category the VBD in a certain
location belongs, to VBD contexts 1-3 or VBD contexts
4-5 (Table 1). In the first case (VBD contexts 1-3) vector
surveillance can entail measuring the spatial and tem-
poral variation in vector abundance and pathogen
prevalence.
Presence/absence data sets would be ideally derived
from databases of local monitoring programs assessing
the spatial and temporal abundance patterns of vectors,
which may be obtained by systematic methods involving
consistent sampling and standardized collection proto-
cols. However, more often data is assembled from
research projects addressing other questions than pre-
sence/absence, or from control agencies. For arthropod
vectors such methods typicall yp r o d u c ed a t ae x p r e s s e d
per unit such as the number of adult mosquitoes per
trap night, or effort such as the number of nymphal
ticks per flagging hour or drag-meters. These measures
are relative numbers and do not estimate density (num-
ber per unit area) or absolute size (total number as mea-
sured in mark-release-recapture methods). Accuracy is
important as thresholds of abundance such as counts
per night are used to make decisions on the density of
the vector-borne health risk or the type of focus and
intensity of control. Precision and standardization are
important if estimates are compared over time and or
space. A sampling program consists of a program
design, data collection and statistical analyses. However
the data analysis is only as informative as the validity of
the samples. Studies specifically designed for the collec-
tion of absence/presence data would be highly desirable.
Since scientific evidence has established the trend of
ongoing climate change related to human activities, the
potential for climate-induced change in distribution pat-
terns of arthropod vectors and their associated patho-
gens has emerged as an area of special concern to
human and animal health. Model simulations of poten-
tial future climate related change in spatial patterns of
distribution or abundance of vectors, distribution or
prevalence of vector-borne disease agents in vector
populations, or distribution or incidence of vector-borne
diseases affecting humans or domestic animals have
been presented [29]. However, when the possible effects
of climate changes on specific vector-borne diseases are
analysed in detail, the results are often inconclusive and
the strength of a potential link weak. In the case of tick-
borne diseases, such as tick-borne encephalitis, climate
is considered just one of many factors, biological and
non-biological that influence tick-borne diseases
dynamics [30]. Future empirical demonstrations of cli-
mate-driven change in spatial and temporal patterns of
ticks and their associated pathogens are entirely depen-
dent on the existence of high-quality field data sets for
current patterns in areas where climate change is likely
to have a significant impact on the vector presence and
abundance [29].
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In theory, vector-borne pathogens can be detected in
donor or recipient individuals (both human and animal),
and in the vector. For monitoring purposes, detection of
pathogens in vectors is often the method of choice as
vectors might accumulate different pathogenic species
from various different sources of reservoir hosts and the
presence of the pathogen in vertebrate host can be
sometimes of short duration (e.g. for arboviruses).
Pathogen detection in wildlife is very laborious and
often not possible because of the protected status of
many wild animals that precludes the sampling from
target organs as is often required for detection. Compa-
nion animals such as dogs and horses have been used
(successfully) as sentinel animals for human infection
[31]. Pathogen detection in vectors collected from
humans give a direct insight in public health relevant
vector species and might also be used for studying
transmission risks. Additional information can be
acquired from ticks collected from livestock, and com-
panion animals. Blood-meal analyses in vectors, in com-
bination with pathogen detection, may be a powerful
tool to determine the relative importance of hosts to the
vector population, and also the distribution and preva-
lence of pathogens in feeding hosts.
One of the major concerns in conducting monitoring
programs to detect pathogens (especially in case of
viruses) in vectors is the handling of field-collected mos-
quitoes and ticks. In case of arbovirus detection, RNA
degradation should be prevented, and vectors should be
maintained in a cold chain through the various handling
procedures or immediately after killing be submerged in
RNA preservative buffer to reduce the risk of pathogen
inactivation [32-34].
Traditional circumstances in the field-collection
might not allow for the maintenance of a cold-chain
or the prompt processing of the mosquitoes (fresh
kill) upon capture. The use of a RNA preservative
might increase RNA stability under adverse condi-
tions but is not recommended when species identifi-
cation is required [35]. The goals of the surveillance
need to be considered when determining the hand-
ling conditions that should be employed. Is there a
need for isolation of infectious virus or does the sim-
ple establishment of the presence of a specific patho-
g e ni nm o s q u i t o e ss u f f i c e ?T h em a i n t e n a n c eo fa
cold chain is absolutely required when infectious
virus needs to be isolated [36]. An important advan-
tage of infectious virus assays is that a wide variety
of pathogens can be detected while RT-PCR assays
only detect those pathogens and strain variants that
the primers are designed to detect. This is in parti-
cular important for (high risk) areas where a variety
of arboviruses might circulate. Employing RT-PCR
detection might lead to failure to detect viruses that
are not suspected to circulate. Especially in low
endemic areas, it is critical to implement a quality
check of the RNA isolated from the arthropods to
avoid false negative results due to the failure to
extract good quality RNA. Several strategies to
implement an internal positive control for RNA iso-
lation in mosquitoes have been described [37,38].
For some pathogens the infection rate is extremely
low, even in highly endemic areas. One option is to ana-
lyse a number of specimens (minimally separated by
species) together in one pool. In general, increasing the
pool size will decrease the test sensitivity. In high ende-
mic areas a loss in sensitivity is more acceptable than in
low endemic and in particular arbovirus-free areas. On
the other hand the total number of mosquitoes that
need to be analysed (and therewith the practical need to
increase pool sizes) will be considerably higher in low
endemic and arbovirus-free areas. The extent of the sen-
sitivity loss with increasing pool sizes will depend on the
virus-mosquito species combination and the detection
assay used (Reusken, Pers. comm.) [39]. Also, increasing
the pool sizes will reduce the ability to estimate accu-
rately the proportion of infected specimens, especially
when proportions are high during an epidemic or sam-
ple sizes are low [40,41]. Infection rates are important
i n d i c a t o r sf o rv i r u st r a n s m i s s i o nr i s k sa l t h o u g hl o w
infection rates do not exclude transmission risks.
Furthermore, increasing pool sizes will increase the pos-
sibility that more than one virus is present in the sample
(e.g. in regions endemic to multiple VBDs), complicating
confirmation of virus or virus strain identification by
sequence analysis. The generalized procedure for arbo-
virus surveillance in mosquitoes is the processing of
pools with a maximum of 50 individual specimens
[32,39,42-44].
Microscopic analyses of vector-lysates have been gra-
dually replaced by PCR-based techniques. PCR-based
techniques greatly improved sensitivity, specificity, and
throughput capacity of the number of samples and
number of pathogens to be tested. However, PCR-based
technologies have some limitations, which should be
taken into account during surveillance activities.
PCR-based methods are based on the detection of
specific DNA sequences: It does not necessarily
mean that viable, infectious microorganisms are
detected! PCR may result in the amplification of a
wrong target DNA or RNA. For the purpose of early
warning, the proportion of false positive test results
should be minimized [45,46]. In that case, confirma-
tion of test results and thus minimizing false-positive
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a DNA hybridization probe, which is often used in
Q-PCR and array-based methods [47], or by sequen-
cing the PCR product and comparing to a reference
database. For pathogen identification, Genbank is
often used but should only be done with caution
because of many errors. Although extremely specific,
misidentification may still occur, especially when
relatively short or highly conserved DNA/RNA-
regions are being used. For surveillance purposes,
sequencing is still a laborious, slow and relative
expensive technique, but second and third genera-
tion sequencing approaches may overcome these dis-
advantages. PCR is also not stage specific (e.g.
malaria). Another obvious disadvantage of PCR is
that it identifies the presence of DNA/RNA with
high sensitivity. PCR may detect (remnants of)
microorganisms present in the blood meal, which
are inactivated, dead and non-infectious to the next
host. A consequence is that PCR can also be used to
determine the previous host of the vector [48].
Other examples are the finding of Borrelia henselae,
Rickettsia typhii and R. prowazeki in questing ticks
[49,50]. Besides aspecific binding, a PCR may fail to
detect a pathogen, simply because it is present below
the detection limit of the PCR, or because of the
presence of inhibitory factors, such as haemoglobin
or chitin. Highly specific primers may also fail to
bind because of the high genetic variability of the
target DNA/RNA. Either using another or multiple
target DNA/RNA fragments of the pathogen of
choice can circumvent this problem.
Surveillance and intervention
Surveillance of vector-borne diseases aims at the accu-
rate and timely measurement of the introduction of vec-
tors and pathogens, the incidence of disease, and the
effect of preventive, control and curative actions taken.
The surveillance feedback system strongly depends on
the actions that will be taken upon the outcomes of the
surveillance. For example, the control option for measles
and mumps is vaccination. A surveillance system mea-
suring newly reported cases of measles and mumps as
the indicator parameter is sufficient. In situations where
more intervention measures need to be considered or
are taken, the identification of indicators that measure
the effect of intervention is more challenging. An inter-
vention, for example, that aims to raise the awareness of
the risk of acquiring Lyme borreliosis through tick bites
might increase the number of reported tick bites or
even erythema migrans, but the number of Lyme
patients with chronic or late-stage symptoms would
decrease. Moreover, the best indicator for an
intervention involving tick control on large mammals
would be the number of ticks on large mammals. How-
ever, acquiring such data is very costly. An alternative
indirect indicator here would be the tick density in the
environment. Obviously, in a feedback VBD surveillance
system (Figure 1), the parameter measured in monitor-
ing of VBDs, vector and pathogen can often also be
used to assess the effectiveness of intervention. The
integration of intervention and surveillance system is
illustrated in Figure 4.
In case the infection is present at an endemic level
(VBD context 1, Table 1) e.g. Lyme borreliosis in the
Netherlands, the indicator requirements of a VBD sur-
veillance feedback system in the human population
resemble those of other notifiable diseases with the
exception of exposure surveillance, which depends on
the human - vector contact patterns. The disease burden
pyramid, complemented with the two additional layers,
becomes suitable for the surveillance system for VBD
and probably all zoonotic diseases.
Decision making
I nt h ep r e c e d i n gp a r a g r a p h s ,w eh a v ea r g u e dt h a tt h e
key objectives of VBD surveillance feedback system are
to understand the epidemiology of VBDs and to provide
adequate information on risk-assessment for decision
makers to decide by disease burden or threat calls for
intervention measures. To this end, local, national and
international (health) authorities need to know in which
situation they find themselves for a given VBD with two
main groups: endemic (Table 1, context 1) or non-ende-
mic (Table 1, context 2-5). For many VBDs, exemplified
with Lyme borreliosis, disease burden assessments are
fraught with difficulties. Measurements of indirect indi-
cators of disease burden with information from the base
levels of the pyramid have proven to be useful [23].
Standardisation and harmonization of indicators of dis-
ease burden or threat are desirable.
When intervention is decided to be desirable, a differ-
ent approach is needed for a VBD belonging to one or
the other main group. Intervention of endemic diseases
can be implemented on either level of the pyramid,
depending on the pathogen and/or vector of interest.
Intervention, however, of a non-endemic VBD should be
implemented on the two base levels of the pyramid.
Once a decision has been made to control a certain dis-
ease (or group/category of diseases) or threat, surveil-
l a n c es h o u l db ec o n d u c t e di no r d e rt om e a s u r et h e
effectiveness of the intervention.
Conclusions
This paper intended to improve the mutual understand-
ing and enhance communication between the commu-
nities of medical entomology and public health. Both
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den or threat of vector-borne diseases and to decide on
intervention measures. To this end, we developed a fra-
mework for a surveillance feedback system for VBDs,
which share many characteristics with other infectious
diseases. However, because of the involvement of a vec-
tor (and non-human reservoirs, in the case of vector-
borne zoonoses), additional issues need to be consid-
ered, as illustrated by the complementary layers to the
disease burden pyramid, together forming the interven-
tion and surveillance pyramid for VBDs.
For surveillance purposes, international, national and
local (health) authorities need to know in which situa-
tion they find themselves for a given VBD (table 1). We
suggest that countries consider implementing a dynamic
database in which this information is established and
kept up to date. This information can then also be
reported to ECDC. ECDC might facilitate this by pro-
viding an international framework/platform comprising
(molecular) epidemiological databases on vectors, patho-
gens, and disease, which is useful for the collection,
sharing and interpretation of the data at both the
national and international level. A clear and qualitative
insight in the current situation will then be available for
risk assessment.
Besides data on the presence of diseases, pathogens or
vectors, convincing data for true absence is essential.
Evidence for the latter is, however, much harder to pro-
vide. Furthermore, insights from recent scientific and
medical developments should be incorporated into the
list in Table 1: (Potential) new vectors and vector-borne
pathogens are reported in the scientific literature fre-
quently, including vector competence. Input from
research and developmental studies are absolute require-
ments to keep the information of Table 1 up to date,
both at the national and international level.
The availability of information, however, to assess the
context of a certain disease situation should be based on
monitoring data, for which availability differs greatly
between regions or countries. Pan-European surveillance
activity could be instrumental for ECDC and their member
states to prioritize their future activities, based on evidence.
When deemed necessary, contingency plans, including
intervention strategies, can be developed and surveillance
activities implemented as integrated part of the VBD sur-
veillance feedback system guiding the Member States.
Interactions between multiple disciplines and responsible
ministries are essential for an effective and efficient early
warning, surveillance and control of vectors and VBDs.
We hope to increase the awareness of VBD situations
in EU, and to present a first step for decisions on the
implementation of more harmonized surveillance activ-
ities by EU member and associate states.
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